- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 1/06 - Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
Patent holdings for IPC class A61P 1/06
Total number of patents in this class: 236
10-year publication summary
|
13
|
5
|
17
|
14
|
10
|
21
|
16
|
22
|
10
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Thetis Pharmaceuticals LLC | 23 |
7 |
| Ltd "valenta-intellekt" | 154 |
5 |
| Société des Produits Nestlé S.A. | 9301 |
4 |
| Janssen Pharmaceutica N.V. | 3376 |
4 |
| BioGaia AB | 199 |
4 |
| enGene, Inc. | 37 |
4 |
| Cinclus Pharma Holding AB | 22 |
4 |
| Nxera Pharma UK Limited | 167 |
4 |
| Allergan, Inc. | 2337 |
3 |
| BGI Shenzhen Co., Limited | 286 |
3 |
| Heptares Therapeutics Limited | 76 |
3 |
| Nippon Chemiphar Co., Ltd. | 227 |
3 |
| Universita degli Studi di Padova | 266 |
3 |
| Landos Biopharma, Inc. | 37 |
3 |
| Fondazione Citta' della Speranza-onlus | 8 |
3 |
| Chain Biotechnology Limited | 10 |
3 |
| Bristol-myers Squibb Company | 4872 |
2 |
| Nestec S.A. | 2657 |
2 |
| Boehringer Ingelheim International GmbH | 4645 |
2 |
| Boehringer Ingelheim Pharma GmbH & Co. Kg | 545 |
2 |
| Other owners | 168 |